Colgate-Palmolive (CL) director defers retainer into 210-share stock grant

Rhea-AI Filing Summary

Newman Brian reported acquisition or exercise transactions in this Form 4 filing.

Colgate-Palmolive director Brian Newman received 210 shares of Common Stock as a grant on April 1, 2026, at $89.05 per share. The award represents a portion of his annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

After this grant, he directly holds 5,534 shares of Colgate-Palmolive Common Stock. In addition, 36 shares are held indirectly through a family trust. This filing reflects routine director compensation rather than an open-market purchase or sale.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Newman Brian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	210	$89.05	$19K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,534 shares (Direct); Common Stock — 36 shares (Indirect, By Family Trust)

Footnotes (1)

1. [object Object]

Key Figures

Grant size: 210 shares Grant valuation price: $89.05 per share Direct holdings after grant: 5,534 shares +1 more

4 metrics

Grant size 210 shares Common Stock award on April 1, 2026

Grant valuation price $89.05 per share Value used for the 210-share director grant

Direct holdings after grant 5,534 shares Common Stock held directly by Brian Newman after transaction

Indirect holdings 36 shares Common Stock held indirectly by family trust

Key Terms

Deferred Compensation Plan for Non-Employee Directors, annual cash retainer, stock unit account, family trust

4 terms

Deferred Compensation Plan for Non-Employee Directors financial

"pursuant to the Deferred Compensation Plan for Non-Employee Directors"

annual cash retainer financial

"Portion of annual cash retainer deferred to a stock unit account"

stock unit account financial

"deferred to a stock unit account pursuant to the Deferred Compensation Plan"

family trust financial

"nature_of_ownership": "By Family Trust""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newman Brian

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		210	A	$89.05	5,534	D
Common Stock								36	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Colgate-Palmolive (CL) director Brian Newman report in this Form 4?

Brian Newman reported receiving 210 shares of Colgate-Palmolive Common Stock as a grant. The award was valued at $89.05 per share and stems from deferring part of his annual cash retainer into the company’s non-employee director deferred compensation plan.

Was Brian Newman’s Colgate-Palmolive (CL) Form 4 transaction an open-market purchase?

No, the transaction was not an open-market purchase. The 210 shares reflect a grant tied to deferring a portion of his annual cash retainer into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors, rather than buying shares on the market.

How many Colgate-Palmolive (CL) shares does Brian Newman hold after this filing?

Following the grant, Brian Newman directly holds 5,534 shares of Colgate-Palmolive Common Stock. The filing also notes an additional 36 shares held indirectly through a family trust, giving investors a clearer picture of his reported equity exposure.

What price per share is associated with Brian Newman’s Colgate-Palmolive (CL) grant?

The 210-share grant is reported at $89.05 per share. This price is used for valuing the compensation award tied to his deferred annual cash retainer, rather than indicating a trade price from an open-market transaction.

What is the Deferred Compensation Plan for Non-Employee Directors at Colgate-Palmolive (CL)?

It is a program that allows non-employee directors to defer portions of their cash retainers into a stock unit account. In this filing, a portion of Brian Newman’s annual cash retainer was deferred, resulting in a grant of 210 Colgate-Palmolive Common Stock shares.